USPTO serial 99191347
NOVOCURE
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- KLUWE, CHERYL D
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with NOVOCURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hara K Jacobs
Hara K Jacobs Ballard Spahr LLP1735 Market Street 51st Fl.Philadelphia, PA 19103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; downloadable mobile application software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; downloadable mobile application software for use in the treatment, evaluation, monitoring and staging of cancer; downloadable software for mobile phones for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; downloadable software and downloadable mobile application software for use in the treatment, evaluation, monitoring and staging of cancer; downloadable software and downloadable mobile application software for capturing, storing, tracking, monitoring, analysing and transmitting medical data; downloadable software and downloadable mobile application software for conducting clinical trials; electronic communication transmission and receiving equipment and instruments for use in the treatment, evaluation, monitoring and staging of cancer; electronic communication transmission and receiving devices for use in the treatment, evaluation, monitoring and staging of cancer; electronic communication transmission and receiving devices for collecting medical data from a medical device that treats cancer and transmitting medical data to the provider of the medical device | ACTIVE | — |
| 035 | Compilation of medical reports, not for research purposes; processing and compilation of medical data, not for research purposes; maintaining patient medical history records and files; providing business information about the administration of patient reimbursement programs designed to assist patients requiring treatment of cancer; business administration of patient reimbursement programs for patients requiring treatment of cancer; information, advisory and consultancy services related to the aforesaid | ACTIVE | — |
| 042 | Software as a service (SaaS) featuring software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; providing temporary use of online non-downloadable software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; providing temporary use of online non-downloadable software for use in the treatment, evaluation, monitoring and staging of cancer; providing temporary use of online non-downloadable software and mobile applications for capturing, storing, tracking, monitoring, analysing and transmitting medical data; providing temporary use of online non-downloadable software and mobile applications for conducting clinical trials; medical research services; calibration of medical apparatus and devices; analysis of statistical data for scientific research; Scientific research in the nature of conducting clinical trials for others; information, advisory and consultancy services related to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 12, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 12, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 12, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 17, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 26, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 26, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 26, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 26, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 26, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 30, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 19, 2025 | NWAP | NEW APPLICATION ENTERED | — |